Study Description: Non-pregnant females age 18 and older who are experiencing syptoms of a vaginal infection (discharge, odor, itching, burning, irritation, redness) may be screened for participation into this study. Potential participants will have a gynecologic exam. The study doctor or nurse practitioner will determine the type of infection present, if any. If the participant has a diagnosis of Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC or yeast infection), or a mixed infection (both bacterial vaginosis and yeast infection), she will be randomized to receive study medication or placebo. Participants with BV will be randomized (like the flip of a coin) to receive either metronidazole gel or placebo gel. Subjects with a vaginal yeast infection (VVC) will be randomized to receive either terconazole gel or placebo gel. Subjects with a mixed infection (both yeast and BV) will be randomized to receive metronidazole gel, terconazole gel, or a combination of both the metronidazole gel and terconazole gel. Participation in the study will last approximately 30 days and will require 3 visits to the clinic during that time.
Principal Investigator: Daron Ferris
Eligibility Criteria: -Non-pregnant females age 18 and older currently experiencing syptoms of a vaginal infection (discharge, odor, itching, burning, irritation or redness) -Must be using an acceptable form of birth control -Must be willing to refrain from sexual intercourse from screening until the follow up visit (about 7 days) -Must be willing to refrain from using vaginal products (douches, spermicidal foams, vaginal lubricants, etc) from the screening visit until the follow up visit (about 7 days)
Compensation: Yes, subjects will be compensated.
Compensation Explanation: Subjects will receive $50 per completed visit.
If you don't see specific studies that interest you, please submit your contact information for future studies.